Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Study Design in Statistics01:15

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Sampling Plans01:23

Sampling Plans

Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compensatory Smoking With Very Low Nicotine Content Cigarettes: A Systematic Review and Meta-Analysis.

JAMA network open·2026
Same author

Robust CATE estimation using novel ensemble methods.

Journal of biopharmaceutical statistics·2026
Same author

Examining covariate-specific treatment effects in individual participant data meta-analysis: Framing aggregation bias in terms of trial-level confounding and funnel plots.

Research synthesis methods·2026
Same author

Aligning cardiac monitoring with American Heart Association Guidelines: Impact on utilization, hemodynamic monitoring, and outcomes.

PloS one·2026
Same author

Jointly modeling multiple endpoints for efficient treatment effect estimation in randomized controlled trials.

Biometrics·2026
Same author

Optimizing sepsis care within a learning health system: qualitatively examining the perspectives of those involved in sepsis care.

Journal of critical care·2025

Related Experiment Video

Updated: May 12, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials.

Wei Zhong1, Joseph S Koopmeiners, Bradley P Carlin

  • 1Department of Biostatistics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.

Contemporary Clinical Trials
|April 16, 2013
PubMed
Summary

This study introduces a flexible two-stage Bayesian clinical trial design for binary outcomes. It allows for sample size reestimation, potentially reducing initial sample sizes and enabling personalized medicine through subgroup analysis.

Keywords:
Bayesian designClinical trialPersonalized medicinePredictive approachSample size reestimationSubgroup analysis

More Related Videos

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Related Experiment Videos

Last Updated: May 12, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Bayesian Statistics

Background:

  • Frequentist sample size calculations for binary outcomes are sensitive to initial event rate assumptions.
  • Misspecified event rates can lead to inadequate or excessive sample sizes in clinical trials.
  • Existing Bayesian methods offer flexibility but may not incorporate interim sample size reestimation.

Purpose of the Study:

  • To introduce a novel two-stage Bayesian clinical trial design with interim sample size reestimation.
  • To generalize existing Bayesian sample size methods to a two-sample setting.
  • To enable adaptive sample size adjustments based on interim data and patient covariates.

Main Methods:

  • A two-stage Bayesian design incorporating a 'conclusiveness' condition for sample size determination.
  • Utilizing a fully Bayesian predictive approach for sample size reestimation at an interim stage.
  • Extending the design to accommodate patient-level covariates using logistic regression for subgroup analysis.

Main Results:

  • The proposed design allows for reduction of an overly large initial sample size when necessary.
  • The method generalizes previous Bayesian sample size approaches to a two-sample context.
  • Demonstrated application in non-Hodgkin lymphoma, incorporating gender as a covariate for subgroup-specific sample size adjustments.

Conclusions:

  • The new two-stage Bayesian design offers a more flexible and efficient approach to sample size determination in clinical trials.
  • Interim sample size reestimation can optimize resource allocation and trial efficiency.
  • The design provides a foundation for personalized medicine by allowing covariate-adjusted sample size calculations within subgroups.